心灵胜过图表:了解老年人群中最重要的是什么
Kelly Kennedy1, Krystal LaNeve1, Lynnelle Tampac1
1The Valley Hospital, 4 Valley Health Plaza, Paramus, NJ, 07652, USA.
概括
通过"最重要的是什么"问题来优先考虑老年人的个人目标,改善了患者的满意度,并与个人需求协调了护理. 这种以患者为中心的方法增强了沟通,并导致了更好的健康结果.
科学领域:
- 老年学是一门学科.
- 医疗保健服务研究 医疗服务研究
- 护理 护理 护理
背景情况:
- 医疗保健系统在为老年人群提供个性化,基于证据的护理方面面临挑战.
- 年龄友好卫生系统倡议的4M框架强调以患者为中心的护理.
- 将患者的目标融入日常护理中对于老年人来说至关重要.
研究的目的:
- 通过将"最重要的是什么" (WMM) 问题整合到护理工作流程和电子健康记录 (EHR) 中,增强以患者为中心的护理.
- 加强医疗保健提供者,患者和家人之间的沟通.
- 提高患者满意度,确保护理与老年人的独特需求保持一致.
主要方法:
- 一项质量改进计划将WMM问题应用于日常护理工作流程中.
- 患者和家人被要求在每个护理班开始时分享个人目标和需求.
- 该WMM问题被集成到电子健康记录 (EHR) 系统中.
主要成果:
- 患者体验得分,特别是护士对个人需求的关注,显著改善.
- 该计划成功地将患者确定的目标纳入了护理规划过程.
- 观察到改善了沟通,护理与患者优先事项的更强的协调.
结论:
- 整合"什么最重要"的问题是为提供个性化,以患者为中心的护理给老年人的有效策略.
- 优先考虑个体患者的目标会带来更有意义的护理体验和改善患者的治疗结果.
- 这种方法加强了护士与病人之间的关系,并提高了整体护理质量.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197


